Please login to the form below

Not currently logged in
Email:
Password:

Docetaxel

This page shows the latest Docetaxel news and features for those working in and with pharma, biotech and healthcare.

Daily Brief:  NICE says no to Zytiga, Genentech and UK biotech sign microbiome deal

Daily Brief:  NICE says no to Zytiga, Genentech and UK biotech sign microbiome deal

Around half of patients unable to tolerate conventional chemotherapy (docetaxel) will be left with no life-prolonging treatment option at this early, but crucial stage of treatment, as Zytiga is the

Latest news

More from news
Approximately 1 fully matching, plus 103 partially matching documents found.

Latest Intelligence

  • The rise of chronic disease in BRIC markets The rise of chronic disease in BRIC markets

    In China there has been a rise in the use of Xeloda in combination with docetaxel as a second and third-line treatment.

  • Pharma deals during April 2013 Pharma deals during April 2013

    Bind more than $180.5m plus tiered royalties. And if that were not enough, the biotech recently secured $20m from its venture backers to fund phase II work on its

  • Detecting and managing NS

    Supported by sanofi-aventis, Succinct worked in close partnership with the UK Oncology Nursing Society (UKONS) to develop a range of patient-centred materials for those women receiving Taxotere (docetaxel) for

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Anthill Agency

Digital communications agency empowering clients through their digital transformation journey. Whether through training, delivering solutions or devising digital strategies, we...

Latest intelligence

Unlocking the potential of science and technology in the UK
Greater collaboration is vital in post-Brexit UK, says Alderley Park leader...
NHS regional footprints
What to expect from 2019...
Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...

Infographics